ELAN

12.94

0.47% 0.06

Dopo l'orario di chiusura: 13.18 0.24 +1.85%

Elanco Animal Health Inc (ELAN)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$12.88

Aprire:

$12.75

Volume 24 ore:

5.10M

Relative Volume:

0.93

Capitalizzazione di mercato:

$6.10B

Reddito:

$4.45B

Utile/perdita netta:

$205.00M

Rapporto P/E:

32.35

EPS:

0.4

Flusso di cassa netto:

$372.00M

1 W Prestazione:

+5.37%

1M Prestazione:

+57.04%

6M Prestazione:

-7.44%

1 anno Prestazione:

-24.06%

Intervallo 1D:

$12.67

$12.99

Intervallo di 1 settimana:

$11.92

$13.21

Portata 52W:

$8.02

$18.80

Elanco Animal Health Inc Stock (ELAN) Company Profile

Nome

Elanco Animal Health Inc

Settore

Healthcare (1155)

Industria

Drug Manufacturers - Specialty & Generic (1)

Telefono

877-352-6261

Indirizzo

2500 INNOVATION WAY, GREENFIELD

Dipendente

9,450

Cinguettio

@Elanco

Prossima data di guadagno

2024-11-07

Ultimi documenti SEC

ELAN's Discussions on Twitter

Confronta ELAN con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
ELAN Elanco Animal Health Inc	12.94	6.10B	4.45B	205.00M	372.00M	0.40
ZTS Zoetis Inc	160.35	69.45B	9.29B	2.52B	2.28B	5.57
HLN Haleon Plc Adr	10.67	47.63B	14.35B	1.85B	0	0.4023
TAK Takeda Pharmaceutical Co Adr	14.00	44.91B	30.08B	710.16M	4.45B	0.2182
TEVA Teva Pharmaceutical Industries Ltd Adr	16.87	20.73B	16.54B	-1.64B	749.00M	-1.45
UTHR United Therapeutics Corp	303.92	13.89B	2.99B	1.21B	1.13B	25.06

Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-12-09	Iniziato	UBS	Buy
2024-12-02	Iniziato	Leerink Partners	Market Perform
2024-09-19	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2024-01-05	Aggiornamento	Stifel	Hold → Buy
2023-12-19	Iniziato	Jefferies	Buy
2023-12-15	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2023-12-07	Iniziato	Exane BNP Paribas	Outperform
2023-04-20	Aggiornamento	Barclays	Equal Weight → Overweight
2022-08-18	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2022-08-16	Downgrade	JP Morgan	Overweight → Neutral
2022-07-21	Downgrade	Goldman	Buy → Sell
2022-07-12	Iniziato	Piper Sandler	Neutral
2021-11-18	Iniziato	Morgan Stanley	Overweight
2021-10-28	Downgrade	Stifel	Buy → Hold
2021-08-05	Ripresa	Credit Suisse	Outperform
2021-06-15	Aggiornamento	Cleveland Research	Underperform → Neutral
2021-05-11	Aggiornamento	Barclays	Underweight → Equal Weight
2021-05-11	Aggiornamento	Gabelli & Co	Hold → Buy
2021-04-15	Iniziato	Stifel	Buy
2021-03-22	Downgrade	Gabelli & Co	Buy → Hold
2021-02-26	Aggiornamento	Credit Suisse	Neutral → Outperform
2020-12-09	Downgrade	Argus	Buy → Hold
2020-11-09	Downgrade	Barclays	Overweight → Underweight
2020-08-20	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2020-08-13	Ripresa	Credit Suisse	Neutral
2020-08-04	Ripresa	Goldman	Buy
2020-07-27	Downgrade	Cleveland Research	Neutral → Underperform
2020-04-02	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2020-01-10	Iniziato	Raymond James	Mkt Perform
2019-12-19	Aggiornamento	BofA/Merrill	Neutral → Buy
2019-11-07	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2019-09-23	Iniziato	Barclays	Overweight
2019-08-26	Downgrade	BofA/Merrill	Buy → Neutral
2019-08-15	Aggiornamento	UBS	Sell → Neutral
2019-05-23	Iniziato	Guggenheim	Neutral
2019-03-18	Aggiornamento	BofA/Merrill	Neutral → Buy
2019-03-13	Ripresa	Morgan Stanley	Equal-Weight
2019-02-12	Iniziato	William Blair	Mkt Perform
2019-01-23	Iniziato	UBS	Sell
2019-01-15	Iniziato	Argus	Buy
2018-10-15	Iniziato	Morgan Stanley	Equal-Weight

Mostra tutto

Elanco Animal Health Inc Borsa (ELAN) Ultime notizie

09:56 AM

Veterinary Medicine Market Generated Opportunities, Future - openPR.com

09:56 AM

07:31 AM

S&P 500 Futures Drop in Premarket Trading; Dick's Sporting Goods, Elanco Animal Health Lag - Barron's

07:31 AM

01:55 AM

Elanco Animal Health Incorporated (NYSE:ELAN) Receives Average Recommendation of “Hold” from Brokerages - Defense World

01:55 AM

May 14, 2025

Tylosin Market Witnessing Steady Growth in Veterinary Applications | Elanco, Huvepharma, Zoetis - openPR.com

May 14, 2025

May 13, 2025

Animal Pharmaceutical Market Expected to Expand | Key Players: Zoetis, Merck Animal Health, Elanco - openPR.com

May 13, 2025

Tower Research Capital LLC TRC Trims Stock Position in Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World

May 13, 2025

May 12, 2025

Waters Corporation, Avantor, Azenta, Bio-Techne, and Elanco Stocks Trade Up, What You Need To Know - Yahoo Finance

May 12, 2025

Elanco Animal Health Incorporated Just Recorded A 117% EPS Beat: Here's What Analysts Are Forecasting Next - Yahoo Finance

May 10, 2025

William Blair Issues Negative Forecast for ELAN Earnings - Defense World

May 10, 2025

Q2 EPS Estimate for Elanco Animal Health Reduced by Analyst - Defense World

May 10, 2025

May 09, 2025

Elanco Animal Health Incorporated (NYSE:ELAN) Q1 2025 Earnings Call Transcript - Insider Monkey

May 09, 2025

May 08, 2025

Elanco (ELAN) Stock Target Raised by Analyst Amid Favorable Quar - GuruFocus

May 08, 2025

Stifel raises Elanco stock price target to $15 from $13 - Investing.com

May 08, 2025

Elanco Animal Health (ELAN) Stock Price Target Raised by Stifel | ELAN Stock News - GuruFocus

May 08, 2025

Elanco (ELAN) Stock Target Raised by Stifel Following Strong Quarter | ELAN Stock News - GuruFocus

May 08, 2025

Elanco Animal Health Incorporated (NYSE:ELAN) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ? - Yahoo Finance

May 08, 2025

Elanco Animal Health First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance

May 08, 2025

Elanco Animal Health (NYSE:ELAN) Shares Gap Up Following Strong Earnings - Defense World

May 08, 2025